Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.7.3483

TERT rs2736098 Polymorphism and Cancer Risk: Results of a Meta-analysis  

Qi, Hao-Yu (Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University)
Zou, Peng (Department of Neurosurgery, the First Affiliated Hospital of Nanjing Medical University)
Zhao, Lin (Department of Neurosurgery, the First Affiliated Hospital of Nanjing Medical University)
Zhu, Jue (Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University)
Gu, Ai-Hua (Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.7, 2012 , pp. 3483-3488 More about this Journal
Abstract
Objective: Several studies have demonstrated associations between the TERT rs2736098 single nucleotide polymorphisms (SNPs) and susceptibility to cancer development. However, there are conflicting results. A systematic meta-analysis was therefore performed to establish the cancer risk associated with the polymorphism. Methods: In this meta-analysis, a total of 6 case-control studies, including 5,567 cases and 6,191 controls, were included. Crude odds ratios with 95% confidence intervals were used to assess the strength of associations in several genetic models. Results: Our results showed no association reaching the level of statistical significance for overall risk. Interestingly, in the stratified analyses (subdivided by ethnicity), significantly increased risks were found in the Asian subgroup which indicates the TERT rs2736098 polymorphism may have controversial involvement in cancer susceptibility. Conclusions: Overall, this meta-analysis indicates that the TERT rs2736098 polymorphism may have little involvement in cancer susceptibility.
Keywords
Telomerase reverse transcriptase gene (TERT); polymorphism; cancer; meta-analysis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Wang Y, Broderick P, Webb E, et al (2008). Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet, 40, 1407-9.   DOI   ScienceOn
2 Wu GY, Hasenberg T, Magdeburg R, Bonninghoff R, Sturm JW, Keese M (2009). Association between EGF, TGF-beta1, VEGF gene polymorphism and colorectal cancer. World J Surg, 33, 124-9.   DOI
3 Xue QC, Pu PY, Yang YS, Shen CH (1990). A survey of 790 cases of astrocytoma. Clin Neurol Neurosurg, 92, 27-33.   DOI
4 Abbas S, Beckmann L, Chang-Claude J, et al (2010) Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women. Breast Cancer Res Treat, 120, 727-36.   DOI
5 Bagheri S, Nosrati M, Li S, et al (2006). Genes and pathways downstream of telomerase in melanoma metastasis. Proc Natl Acad Sci USA, 103, 11306-11.   DOI   ScienceOn
6 Broderick P, Wang Y, Vijayakrishnan J, et al (2009). Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study. Cancer Res, 69, 6633-41.   DOI
7 Chen H, Chen Y, Zhao Y, et al (2011). Association of sequence variants on chromosomes 20, 11, and 5 (20q13.33, 11q23.3, and 5p15.33) with glioma susceptibility in a Chinese population. Am J Epidemiol, 173, 915-22.   DOI
8 DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.   DOI
9 Egger M, Davey SG, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.   DOI
10 Gago-Dominguez M, Jiang X, Conti DV, et al (2011). Genetic variations on chromosomes 5p15 and 15q25 and bladder cancer risk: Findings from the Los Angeles-Shanghai bladder case-control study. Carcinogenesis, 32, 197-202.   DOI   ScienceOn
11 Gudmundsson J, Besenbacher S, Sulem P, et al (2010). Genetic correction of PSA values using sequence variants associated with PSA levels. Sci Transl Med, 2, r62-92.
12 Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.   DOI
13 Jin EC, Kang HG, Jin SJ, et al (2009). Polymorphisms in telomere maintenance genes and risk of lung cancer. Cancer Epidemiology Biomarkers and Prevention, 18, 2773-81.   DOI
14 Landi MT, Chatterjee N, Yu K, et al (2009). A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet, 85, 679-91.   DOI
15 Lantuejoul S, Salon C, Soria JC, Brambilla E (2007). Telomerase expression in lung preneoplasia and neoplasia. Int J Cancer, 120, 1835-41.   DOI   ScienceOn
16 MANTEL N, HAENSZEL W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
17 Lau J, Ioannidis JP, Schmid CH (1997). Quantitative synthesis in systematic reviews. Ann Intern Med, 127, 820-6.   DOI   ScienceOn
18 Little MP, de Vathaire F, Shamsaldin A, et al (1998). Risks of brain tumour following treatment for cancer in childhood: modification by genetic factors, radiotherapy and chemotherapy. Int J Cancer, 78, 269-75.   DOI
19 Liu Z, Li G, Wei S, et al (2010). Genetic variations in TERT-CLPTM1L genes and risk of squamous cell carcinoma of the head and neck. Carcinogenesis, 31, 1977-81.   DOI
20 Martinez P, Blasco MA (2011). Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins. Nat Rev Cancer, 11, 161-76.   DOI
21 McKay JD, Hung RJ, Gaborieau V, et al (2008). Lung cancer susceptibility locus at 5p15.33. Nat Genet, 40, 1404-6.   DOI
22 Munafo MR, Clark TG, Flint J (2004). Assessing publication bias in genetic association studies: evidence from a recent meta-analysis. Psychiatry Res, 129, 39-44.   DOI
23 Nosrati M, Li S, Bagheri S, et al (2004). Antitumor activity of systemically delivered ribozymes targeting murine telomerase RNA. Clin Cancer Res, 10, 4983-90.   DOI
24 Shete S, Hosking FJ, Robertson LB, et al (2009). Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet, 41, 899-904.   DOI   ScienceOn
25 Pharoah PD, Dunning AM, Ponder BA, Easton DF (2004). Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer, 4, 850-60.   DOI
26 Rafnar T, Sulem P, Stacey SN, et al (2009). Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet, 41, 221-7.   DOI   ScienceOn
27 Savage SA, Chanock SJ, Lissowska J, et al (2007). Genetic variation in five genes important in telomere biology and risk for breast cancer. Brit J Cancer, 97, 832-6.   DOI   ScienceOn